Cuál es el precio por General Biologicals Corporation (4117)

Precio por General Biologicals Corporation (4117) es de$0.31640033

Cuál es la capitalización de mercado por General Biologicals Corporation (4117)

Capitalización de mercado por General Biologicals Corporation (4117) es $22.25M

Ganancias de General Biologicals Corporation (4117)

General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.

Año	Ganancias	Cambiar
Not enough data for the provided dates.

Año

Ganancias

Cambiar

Not enough data for the provided dates.

Empresa	Ganancias	Diferencia de ganancias	País
STERIS plc STE.US	$1.09B	-	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	-	-	CN
Ypsomed Holding AG YPSN.SW	-	-	CH
Medacta Group S.A. MOVE.SW	-	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	-	-	CN

Empresa

Ganancias

Diferencia de ganancias

País